Divi Laboratories Q3 Results: Pharma giant records a 17% profit surge to Rs 358 crore.
Divi Laboratories Q3 Results: The company’s operational performance showed weakness, with its earnings before interest, taxes, depreciation, and amortization (EBITDA) reaching Rs 479 crore, marking an increase of approximately 19.6% from Rs 409 crore. Divi’s Laboratories witnessed a 17 percent year-on-year (YoY) increase in its consolidated profit to Rs 358 crore for the December quarter….